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Abstract  
This study exploits the information potential of comprehensive two-dimensional gas chromatography 
configured with a parallel dual secondary column-dual detection by mass spectrometry and flame ionization 
(GC×2GC-MS/FID) to study changes in urinary metabolic signatures of mice subjected to high-fructose diets. 
Samples are taken from mice fed with normal or fructose enriched diets provided either in aqueous solution or 
in solid form and analyzed at three stages of the dietary intervention (1, 6, and 12 weeks). 
Automated Untargeted and Targeted fingerprinting for 2D data elaboration is adopted for the most 
inclusive data mining of GC×GC patterns. The UT fingerprinting strategy performs a fully automated peak-
region features fingerprinting and combines results from pre-targeted compounds and unknowns across the 
sample-set. The most informative metabolites, with statistically relevant differences between sample groups, 
are obtained by unsupervised multivariate analysis (MVA) and cross-validated by multi-factor analysis (MFA) 
with external standard quantitation by GC-MS.  
Results indicate coherent clustering of mice urine signatures according to dietary manipulation. 
Notably, the metabolite fingerprints of mice fed with liquid fructose exhibited greater derangement in fructose, 
glucose, citric, pyruvic, malic, malonic, gluconic, cis-aconitic, succinic and 2-keto glutaric acids, glycine acyl 
derivatives (N-carboxy glycine, N-butyrylglycine, N-isovaleroylglycine, N-phenylacetylglycine), and hippuric 
acid. Untargeted fingerprinting indicates some analytes which were not a priori pre-targeted which provide 
additional insights: N-acetyl glucosamine, N-acetyl glutamine, malonyl glycine, methyl malonyl glycine, and 
glutaric acid. Visual features fingerprinting is used to track individual variations during experiments, thereby 
extending the panorama of possible data elaboration tools.  
 
 
Key-words: comprehensive two-dimensional gas chromatography-mass spectrometry; parallel dual secondary 
column-dual detection; fructose-induced metabolic derangements; urine metabolic profiling; Untargeted and 
Targeted fingerprinting  
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Introduction 
The dietary intake of fructose has markedly and rapidly increased over recent decades due to 
consumers’ preferences for sugar-sweetened beverages and sugar-rich processed foods [1]. This trend has 
been associated with increased prevalence of metabolic diseases, such as dyslipidemia, insulin resistance, and 
nonalcoholic fatty liver diseases (NAFLD) [2, 3]. All these phenomena are related to the high lipogenic power of 
fructose [4] that promotes lipid deposition in ectopic tissues, such as liver and skeletal muscle, even without 
impacting body weight and adipose tissue mass [5, 6]. 
Recent findings have demonstrated that liquid and solid high-sugar diets differentially modulate 
feeding behavior, intestinal sugar transporters, and hormone expression [7]. This experimental evidence 
suggests that not only the type (e.g. fructose vs. glucose), but also the form (liquid vs. solid) of sugars may 
significantly affect the development of obesity, insulin resistance, and/or fatty liver disease. Despite the paucity 
of experimental data, this topic deserves better elucidation as sweeteners, including fructose, can be ingested 
in both liquid and solid formulations.  
To date, the specific effects of intake of different forms of fructose, liquid or solid, on intestine integrity 
and microbiota, and hepatic outcomes, have not been investigated. Hence, this study was designed to 
elucidate the toxicological profile of high fructose intake in the intestine and liver, to determine the differential 
impact due to the sugar administration forms [8] and to evaluate its differential impact on urine metabolic 
signatures. C57 male mice were fed with either a standard diet plus water (SD), a standard diet plus 60% 
fructose syrup (L-Fr), or a 60% solid fructose plus water (S-Fr), for 12 weeks. Within this context of 
investigation, urinary metabolic signatures could provide some insights on the mechanisms underlying the 
toxicological effects revealed by physio-pathological assessments, with further information on the kinetics of 
the metabolic derangements.  
To qualitatively and quantitatively track changes in primary metabolites in the mice urine [9], two-
dimensional comprehensive gas chromatography with mass spectrometry (GC×GC-MS) represents one of the 
most advanced and informative hyphenated GC platforms currently available. Thanks to its separation power, 
sensitivity, and structured bi-dimensional (2D) patterns for chemically related compounds, detailed profiles and 
fingerprints of complex biological samples can be comprehensively evaluated [10, 11].  
For these analyses, a GC×GC system with parallel dual secondary column-dual detection configuration 
(GC×2GC-MS/FID) was adopted to maximize the overall separation power and limit second-dimension (2D) 
column overloading. This configuration improves quantitative reliability and response linearity over a wider 
concentration range [10, 12]. It operates at close-to-optimal 2D linear velocities in both chromatographic 
dimensions and doubles the secondary-column loading capacity, with positive effects on overall system 
orthogonality, efficiency, and selectivity [13–17]. In addition, advanced pattern recognition methodologies that 
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combine untargeted and targeted investigation for the most inclusive fingerprinting (i.e. UT fingerprinting) [18] 
by GC×2GC-MS/FID are employed to exploit the information potential encrypted in mice urinary signatures, 
while also providing convenient tools for visual feature inspection to follow signature changes over time. 
 
Materials and Methods 
Reference compounds and solvents 
All chemicals were from Sigma-Aldrich (Milan, Italy): 
a) pure standards of n-alkanes (from n-C9 to n-C25) for system evaluation and Linear Retention Index (ITS) 
determination;  
b) pure standards for quantitative determinations and/or identity confirmation of pyruvic acid, lactic acid, 
malonic acid, succinic acid, malic acid, 2-ketoglutaric acid, 3-hydroxybutirric acid, fumaric acid, 2-keto-3-
metilvaleric acid, aspartic acid, hippuric acid, citric acid, uric acid, L-alanine, L-valine, L-leucine, L-proline, 
glycine, L-threonine, L-tyrosine, L-phenylalanine, L-isoleucine, L-methionine, L-cysteine, L-ornithine, L-
triptophan, xylitol, ribitol, fructose, galactose, glucose, mannitol, myo-inositol, glycerol, palmitic acid, stearic 
acid, creatinine and the internal standards (ISTDs) 4-fluorophenylalanine (QC for derivatization), and 1,4-
dibromobenzene (QC for GC normalization); 
c) derivatization reagents O-methylhydroxylamine hydrochloride (MOX) and N-methyl-N-
(trimethylsilyl)trifluoroacetamide (MSTFA); 
d) HPLC-grade solvents: methanol, pyridine, n-hexane, dichloromethane and toluene. 
 
Samples 
Four-week-old male C57BL/6J mice (n=18) (Harlan-Italy; Udine, Italy) were housed in a controlled 
environment at 25±2 °C. All the animals were fed with a normal pellet diet for 1 week (T1) prior to the 
experimentation. Mice were divided into three groups: a group fed a standard diet and drinking tap water (CS 
group, n = 6), a group fed a standard diet and drinking a 60% fructose syrup (FL group, n = 6), and group fed a 
60% fructose solid diet and drinking tap water (FS group, n = 6), for twelve weeks. Dietary compositions (Sniff 
Spezialdiäten GmbH, Soest, Germany) are detailed in Table 1. All groups received drink and food ad libitum. 
Animals were cared in compliance with the European Council directives (No. 86/609/EEC) and with the 
Principles of Laboratory Animal Care (NIH No. 85–23, revised 1985). The experimental protocol was approved 
by the Turin University Ethics Committee (permit number: D.M. 94/2012-B). Urine samples were collected at 1 
week (Basal) and after 6, and 12 weeks (T6 and T12) of dietary intervention, then immediately quenched on 
liquid nitrogen and stored at -80°C until derivatization/analysis. For urine collection, conscious mice were 
individually placed in metabolic cages with free access to water for 16 hours.  
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Urine samples were submitted to a standard derivatization protocol [19] consisting of the following 
steps: 80 µL of urine and a suitable volume of ISTD (4-fluorophenylalanine solution at 10 g/L) were carefully 
mixed (Whirlimixer vortex, Fisher Scientific, Loughborough, Leicestershire, UK). Then, the solution was dried 
under a gentle stream of nitrogen before the addition of 60 µL of MOX. The resulting solution was incubated 
for 2 hours at 60°C. Next, 60 µL of MSTFA were added and the mixture was incubated at 60 °C for one hour. 
The resulting sample solution was spiked with 1,4-dibromobenzene at 50 mg/L final concentration and diluted 
in toluene at a final volume of 200 μL. Analyses were immediately run by duplicate injections for each sample; 
samples were randomized within a 24 h time frame after derivatization.  
 
GC×2GC-MS/FID instrument set-up  
GC×GC analyses were run with the following system configuration: a MPS-2 multipurpose auto-sampler 
(Gerstel GmbH, Germany) was integrated with an Agilent 6890 GC unit coupled to an Agilent 5975C MS 
detector (Agilent, Little Falls, DE, USA) operating in EI mode at 70 eV. The GC transfer line was set at 300°C. An 
Auto Tune option was used and the scan range was set to m/z 50-450 with a scanning rate of 12,500 amu/s to 
obtain a spectra generation frequency of 20 Hz. The Flame Ionization Detector (FID) was operated as follows: 
base temperature 300°C, H2 flow 40 mL/min, air flow 350 mL/min, make-up (N2) 20 mL/min, and sampling 
frequency 200 Hz. 
The column set consisted of a first-dimension (1D) column of 30 m × 0.25 mm dc × 0.25 μm df SE52 (95% 
polydimethylsiloxane, 5% phenyl) connected to two second-dimension (2D) columns of equivalent length of 1.4 
m × 0.1 mm dc × 0.10 μm df OV1701 (86% polydimethylsiloxane, 7% phenyl, 7% cyanopropyl). Connections 
between the primary and the two secondary columns were by a SilFlow™ GC 3 Port Splitter (SGE Ringwood, 
Victoria, Australia).The secondary column toward the MS detector was connected to a Quick Swap unit (G3185, 
Agilent, Little Falls, DE, USA) and to an auxiliary electronic pressure controller (EPC) consisting of a one channel 
Pneumatics Control Module (G2317A, Agilent, Little Falls, DE, USA). The restrictor capillary in the GC-MS 
transfer line was of 0.17 m x 0.1 mm dc. A schematic picture of the system configuration is provided as 
supplementary information (Supplementary Figure 1 - SF1). All columns and capillaries were from Mega 
(Legnano, Milan, Italy). Helium carrier gas was delivered at constant flow with initial head pressure pi 255.0 KPa 
and the auxiliary gas (He) for MS outlet pressure correction was delivered at 39.9 KPa (relative) [13, 14, 20]. 
The estimated split ratio between MS/FID was 50:50. 
Injections for the analysis of both urine samples and n-alkanes for Linear Retention Indices 
determination ITS, were by a MPS-2 sampler (Gerstel GmbH, Germany) under the following conditions: 
split/splitless injector, split mode, split ratio 1/20, injector temperature 290°C, and injection volume 2µL. The 
oven temperature programme was 60°C (1 min) to 300°C (10 min) at 4.0°C/min. 
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The system was equipped with a two-stage KT 2004 loop-type thermal modulator (Zoex Corporation, 
Houston, TX) cooled with liquid nitrogen and controlled by Optimode™ V.2 (SRA Instruments, Cernusco sul 
Naviglio, MI, Italy). The hot jet pulse time was set at 350 ms, modulation time was 5 s, and the cold-jet total 
flow was progressively reduced with a linear function from 30% of Mass Flow Controller (MFC) at initial 
conditions to 5% at the end of the run. Loop dimensions were chosen on the basis of the expected carrier 
linear velocities to ensure that two-stage band focusing and release were performed for each modulation 
stage. The first 0.6 m of the 2Ds were wrapped in the metal slit of the loop-type modulator.  
 
GC-MS instrument set-up 
GC-MS analyses were run with the following system configuration: an MPS-2 multipurpose auto-
sampler (Gerstel GmbH, Germany) was integrated with an Agilent 6890 GC unit coupled to an Agilent 5975C 
MS detector (Agilent, Little Falls, DE, USA) operating in EI mode at 70 eV. The GC transfer line was set at 300°C. 
An Auto Tune option was used and the scan range was set to m/z 35-550 with a scanning rate of 2,500 amu/s.  
The column consisted of 30 m × 0.25 mm dc × 0.25 μm df SE52 (95% polydimethylsiloxane, 5% phenyl) from 
Mega (Legnano, Milan, Italy). The carrier gas was helium delivered at constant flow (1.0 mL/min) with initial 
head pressure pi 255.0 KPa. 
Injections for the analysis of both urine samples, standard calibration solutions and n-alkanes for Linear 
Retention Indices determination ITS, were by a MPS-2 sampler (Gerstel GmbH, Germany) under the following 
conditions: split/splitless injector, split mode, split ratio 1/20, injector temperature 290°C, and injection volume 
2µL. The oven temperature programme was 80°C (2 min) to 140°C at 10.0°C/min then to 240°C at 4°C/min up 
to 290°C (5 min) at 10°C/min. 
 
Raw data acquisition and GC×GC data handling  
Data were acquired by Agilent MSD ChemStation ver E.02.01.00 and processed using GC Image GC×GC 
Software version 2.6 (GC Image, LLC Lincoln NE, USA). Statistical analysis was performed by XLSTAT (Addinsoft, 
New York, NY USA) and heat map visualization by GENE-E v 3.0.77 (Broad Institute, Inc. Cambridge, MA, USA). 
 
“UT fingerprinting” work-flow 
The 2D data elaboration work-flow is illustrated in Figure 1. It was optimized and validated in a 
previous study dealing with the fingerprinting of complex volatile fractions from Extra Virgin Olive oil samples 
[18]. It combines untargeted and targeted pattern recognition approaches for the most inclusive fingerprinting. 
In the present study, FID data, although acquired in parallel with MS detection, were not considered because 
several co-elutions occurred on informative targeted peaks.  
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2D-data processing used the template matching strategy developed by Reichenbach et al. [21]. The 
approach uses metadata collected from 2D peak patterns (retention times, MS fragmentation patterns, and 
detector responses) and establishes reliable correspondences between the same chemical entities across 
multiple chromatograms. The output is a data matrix of aligned 2D peaks and/or peak-regions and related 
metadata (1D and 2D retention times, compound names for target analytes, fragmentation pattern, single ions 
or total ions response) available for comparative purposes and further processing [13, 14, 22].  
Targeted analysis (Step 1 - Figure 1) focused on about 53 compounds reliably identified by matching 
their EI-MS fragmentation pattern (NIST MS Search algorithm, ver 2.0, National Institute of Standards and 
Technology, Gaithersburg, MD, USA, with Direct Matching threshold 900 and Reverse Matching threshold 950) 
with those collected in commercial (NIST2014 and Wiley 7n) and in-house databases. As a further parameter to 
support identification, Linear Retention Indices (ITS) were considered and experimental values were compared 
with tabulated reference indices. Analyte retention indices, both experimental ITS and reference, are listed in 
Table 2 together with their retention times (1tR min and 2tR sec) and relative standard deviations (RSD% over 
108 runs). 
Untargeted analysis (Step 2 - Figure 1) was based on peak-regions features [23, 24] and was performed 
automatically by GC Image Investigator™ R2.6 (GC-Image LLC, Lincoln NE, USA). The untargeted analysis 
included all peak-regions above a fixed peak response threshold (5,000 counts for the MS detection channel) 
together with targeted peaks from Step 1. This approach [11, 14, 18, 23–25] (see also Section Targeted 
quantitative fingerprinting) aligned the 108 chromatograms (6 mice × 3 diet groups × 3 time points × 2 
analytical replicates) using a set of registration peaks to produce a composite chromatogram from which 
feature peak-regions were extracted. Then, the template with these peak-regions and target peaks was aligned 
with each of the 108 chromatograms for quantitative evaluation. The resulting data matrix was 108 × 380 
(samples × reliable peak-regions). Response data were normalized twice: a) Normalized 2D-Peak Volumes were 
firstly divided by 1,4-dibromobenzene (ISTD) response and then b) over the total image percent response. 
Aligned 2D peak-regions normalized responses were used for multivariate analysis (MVA) after standardization 
and results cross-compared to those from target peaks distributions. (See Section Targeted quantitative 
fingerprinting for the results discussion.) 
 Significance tests were performed on targeted peaks to evaluate the informative role of single analytes 
in describing the phenomenon under study. The Kruskall-Wallis test followed by Dunn’s evaluation was 
performed on analytes normalized response and considering as sample classes the three diet groups. Results 
are reported in Table 2 (alpha =0.05).  
Visual features fingerprinting, with pair-wise image comparison, also was performed (Step 3 of Figure 
1) with “colorized fuzzy ratio” rendering mode [26]. The algorithm computes the difference at each data 
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datapoint (i.e., the output of the detector at a point in time) between pairs of TIC chromatograms. These 
differences are mapped into Hue-Intensity-Saturation (HIS) color space to create an image for visualizing the 
relative differences between image pairs in the retention-times plane [26]. A detailed description is provided in 
Section ”Urine fingerprint evolution by visual features analysis”. 
 
Quantitative profiling by GC-MS: method performance verification 
Validation of the GC-MS quantitative method followed a previous protocol [25] on a three-weeks-over-
two-months period, characterizing the following parameters: precision, linearity, accuracy, and Limit of 
Quantitation (LOQ) [25, 27, 28]. Precision data (intra and inter-week precision on retention times and 2D Peak 
Volumes on analytes target ions - Ti) were evaluated by replicating analyses during the entire period. Linearity 
was assessed by linear regression analyses within the working range, over at least six different concentration 
levels. Experimental results on linearity, precision (at 10 mg/L), and Limit of Quantification are reported as 
supplementary information in Supplementary Table 1 (including analytes target and qualifier ions, calibration 
ranges, regression curve equations, determination coefficients R2, limit of quantitation LOQ, and precision on Ti 
peak areas at 10 mg/L calibration level with 9 replicates).  
The LOQ was experimentally determined by analyzing decreasing concentrations of standard 
calibrating solutions. Each sample was analyzed in triplicate, and the LOQ was the lowest concentration for 
which instrumental response (Normalized Peak Area based on Ti response) reported an RSD% below 15 %, 
across replicates [29]. 
Calibration solutions for quantitative determination were prepared by mixing single-component 
Standard Mother Solutions at 10 g/L in suitable solvents (acetone or toluene) and adjusting the final volume up 
to the required concentration. Each solution was then submitted to derivatization (Section Samples) and 
directly analyzed. Calibration levels investigated were: 100 mg/L, 40 mg/L, 30 mg/L, 15 mg/L, 10 mg/L, 5 mg/L, 
1 mg/L, 0.5 mg/L, and 0.1 mg/L. 4-fluorophenylalanine, i.e. the Internal Standard for derivatization quality 
control was at 10 mg/L. 
 
Results and discussion 
The goal of the study was to evaluate the potential of an integrated data processing approach that 
combines untargeted and targeted elaboration (i.e., peak-region features, peaks, and visual features methods) 
to achieve highly effective fingerprinting from 2D patterns obtained by GC×GC and parallel dual secondary 
column-dual detection configuration. The work-flow, adapted from a previous study to combine untargeted 
and targeted investigation, is comprehensive yet efficient and fully supported by commercial software. 
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The sample set under study posed several analytical challenges related to the great compositional 
variability and complexity of the mice urine samples due to: (a) individual variations to diet manipulation; (b) 
timing of observation across the study; and (c) interfering chemicals from both derivatization and metabolic 
cages reservoirs. In this context, the combination of two parallel secondary columns was advantageous 
because this configuration results in higher 2D column loadability and lower carrier gas velocities in the 2D, 
thereby producing slightly wider and symmetrical peaks compatible with fast quadrupole detection. In 
addition, the dual detection provides complementary information: e.g. the MS provides essential information 
for identity confirmation and/or identification and supports highly specific untargeted cross-comparisons [13, 
25, 30].  
The UT fingerprinting data analysis work-flow is efficient because of the full integration of targeted 
(known compounds) with untargeted (peak-regions of detected 2D peaks) feature analysis, especially with 
exclusion of uninformative chromatogram regions (solvent peaks/strikes and column bleeding) or single 2D-
peaks (derivatization artifacts) from the template and data processing. A detailed discussion on these aspects is 
provided in the following sections together with a brief interpretation of the experimental results. Insights into 
the evolution of individual metabolic signatures also are gleaned by combining UT fingerprinting and visual 
features investigation. 
 
“UT fingerprinting” results  
Mice urine samples analyzed in this study are listed in Table 1 together with dietary compositions and 
collection times. The total number of runs was 108, with 3 diet groups × 6 mice-per-group × 3 collection points 
(timing).  
The first step of the data elaboration work-flow aimed at chemical characterizing the urine profiles. 
Fifty three analytes, listed in Table 2, were reliably identified, including several aminoacids and related 
derivatives (glycine, hexanoylglycine, N-butyrylglycine, N-crotonylglycine, N-isovaleroylglycine, N-
phenylacetylglycine), branched-chain amino acids - BCAA (leucine, isoleucine and valine), some carboxylic acids 
- TCA (cis-aconitic acid and citric acid) succinic acid, ,malic acid, α-ketoglutarate and fumaric acid, 
monosaccharides (fructose, glucose galactose, sucrose), and polyalcohols (myo-inositol, xylitol, glycerol, 
ribitol). Some analytes were of interest for the study because of their metabolic role is well defined and 
correlated with the dietary manipulation.  
For example, hippuric acid is an acyl-glycine derivative; β-hydroxybutyric acid is involved in the 
synthesis and degradation of ketone bodies; and inorganic phosphate is related to the fructose 
phosphorylation status. BCAAs and their related metabolites have been demonstrated to correlate with 
development of insulin resistance (IR) in both rats and humans [31]. In the adipose tissue of patients with 
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obesity and type-2 diabetes mellitus (T2DM) with IR, the expression of genes encoding the enzymes of BCAA 
metabolism is significantly decreased through an undefined mechanism, leading to increased plasma levels of 
BCAAs, which persistently activate mTOR complex 1 (mTORC1), resulting in insulin resistance through the 
phosphorylation of insulin receptor substrate 1 (IRS-1) [32].  
A first insight on the informative role of the selected known targets in describing the effects on the 
urinary metabolite fingerprint induced by the three dietary regimens was obtained by Principal Component 
Analysis on the targeted data and considering the Normalized 2D-Peak Responses (TIC-MS detection channel) 
as quantitative descriptors. Analytes that were not detected in some samples were included in the variables list 
and their response arbitrarily assigned at 5,000 counts corresponding to the 2D Peaks Volume detection 
threshold adopted for peak detection.  
The PCA results on all targets × samples (53 × 108), illustrated in Figure 2A as scores plot, were 
connoted by a limited descriptive potential: the first two components (F1 - F2) accounted for only the 35% of 
the total variability without a clear independent sub-classification of diet regimens (control diet-CS, liquid 
fructose diet-FL, and solid fructose diet-FS). Still, most of samples derived from mice fed by liquid fructose 
solution were grouped in the IVth quadrant, as shown by confidence ellipses (green oval for p = 95%). CS group 
(blue tags) was less dispersed and co-clusterized with the FS group (purple tags). Possible explanations include 
the high biological variability, a limited descriptive potential of some targets included in the elaboration, and 
the presence of confounding variables.  
Next, the set of targeted analytes was sieved to include just those with a statistically relevant variability 
between classes and/or those detected in just one sub-population. The criterion adopted was driven by the 
Fisher test; those with a Fcalc < Fcrit; with Fcrit (2, 6) = 5.14 (α=0.5) were excluded from further computations.  
Figure 2B illustrates PCA results based on the 37 most informative targets. The total variability 
explained by the first two components increases to 46% and the three groups are more clearly distinguishable. 
The CS and FS sub-populations reasonably overlap due to the expected lower systemic absorption of fructose 
(confirmed by serum metabolomics - data not shown). The lower bioavailability of fructose from FS diet seems 
to minimally impact the systemic metabolism derangements; however, the effect of higher fructose systemic 
distribution is evidenced by separately processed data from control (CS) and liquid fructose (FL) populations 
(Figure 2C).  The group of FL individuals is differentiated from CS mice along F1 (accounting for the 32% of the 
total variability) while the timing of experiments is coherently distributed along F3 from bottom (FL T1) to the 
top (FLT 12). The first and the third principal components (F1 and F3) accounted here for about 42.4% of the 
total variance.  
Within the group of most informative analytes distinguishing FL vs. CS, it is interesting to observe the 
contribution in the FL samples of the timing of the experiment (along F3 from bottom to top) of: (a) fructose 
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(with its two forms), glucose, galactose, ribitol, uric acid and threonine mostly contributing along F3 to 
discriminate week 1 samples against the others; (b) citric acid, pyruvic acid, malic acid, succinic acid and 2-keto 
glutaric acid, gluconic and cis-aconitic acid characterize 6 weeks of diet regimen samples; (d) malonic acid, 
glycine acyl derivatives (N-carboxy glycine, N-butyrylglycine, N-isovaleroylglycine, N-phenylacetylglycine) and 
hippuric acid closely related with 12 weeks of diet manipulation.  
Univariate statistics for Normalized 2D-Peak Responses between sub-populations, visually illustrated by 
scatter diagrams of Figure 3, shows interesting trends. Fig. 3A shows fructose trend (the two detectable forms 
were both included and their normalized responses summed) between samples classes (e.g., CS, FL and FS).  
Results for FL sub-population are connoted by a greater dispersion. An insight on FL sub-population 
suggests that there was a differential metabolic derangement along timing as a function of the dietary 
treatment. By mapping independently the normalized response of fructose isomers for FL samples at the three 
sampling time (e.g., 1, 6 and 12 weeks) a negative trend of excreted fructose is denoted.  
Phenyl acetyl glycine is another analyte showing a characteristic trend between sub-classes. It 
contributes in characterizing samples collected at 12 weeks of liquid fructose feeding (FL T12) and its trend 
between sub-populations is connoted by a meaningful average difference between CS vs. FL and CS vs. FS (Fig. 
3B). In fact, it is more abundant in the urine of mice fed by fructose independently by its supplemented form. 
In addition, its relative abundance in FL and FS sub-populations has relatively large dispersion (CV% was 50 and 
63 respectively), most probably due to the kinetics of metabolic derangement. By observing the profile of 
phenyl acetyl glycine in the FL sub-population at 1, 6 and 12 weeks, the incremental trend over time is evident 
(Fig. 3B right end) and  accompanied by a lower dispersion of results (CV% is 50% at T1, 22% at T6, and 18% at 
T12). 
To see the effect of a solid fructose diet, a PCA was conducted by excluding the FL sub-population. The 
resulting scores plot is shown in Figure 2D. In this case, the differentiation between FS diet and controls is less 
evident although samples are distributed along F1 that explains the 25% of the total variance (i.e., 42.45%). In 
this case, the most informative variables were: glucose, hippuric acid (a glycine metabolite) and uric acid, more 
abundant in FS samples compared to CS; tartaric acid, exclusively present in the FS urines; and acyl glycine 
derivatives (N- carboxyl glycine, N-butyryl glycine and isovaleroil glycine), more abundant in the FS samples at 
the latest stage of diet manipulation (T 12 weeks). Fructose also was present in the group of most informative 
analytes (contributing 8% for the F1-explained variance). 
The presence of higher glucose concentrations in FL and FS sub-populations, illustrated in Figure 4, 
could be explained by saturation of transporters as a consequence of serum distribution. Similarly, the high 
levels of glycine acyl derivatives is consistent with previous studies reporting glycine as biomarker of early 
diabetes onset [33]. Intriguingly, elevated glycine levels recently have been suggested to provide some 
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protection from fructose’s deleterious effects. In fact, glycine has the potential to oppose the formation of 
Amadori products and Advanced Glycation Endproducts (AGEs. Further, through the activation of glycine- 
gated chloride channels present in intestinal L-cells and pancreatic α-cells, glycine may stimulate GLP-1 and 
glucagone release, which work in complementary ways to promote fatty acid oxidation and oppose fructose-
evoked lipogenesis in the liver. With a similar mechanism, glycine antagonises Kupffer cell activation, which 
exacerbates fructose-induced steatosis. So, the increased levels of glycine and derivatives in individuals 
submitted to a fructose-enriched diet could be an attempt of the organism to defend itself from the fructose 
impact [34].  
By extending the explorative investigation to all untargeted peak-regions covered by the UT 
fingerprinting (showed as red graphics in 2D chromatograms of Figure 5A), a cross-validation of previous 
results was obtained and further informative variables revealed. Figure 6A shows the results (score plot) of the 
PCA run by including untargeted peak-regions connoted by a meaningful variation across the set (F value > 5.14 
- i.e., 266 over 380 peak-regions) from all individuals. Here, the combination of the first and the third principal 
components (F1 and F3) accounts for the 52% of the total variance; a better result if compared to the targeted 
analysis alone (Figure 2B - Total explained variance 42%). The more informative variables for the FL sub-set 
against the control (CS) and the solid fructose diet (FS) are: feature #98 (25.37min - 1.89 s), corresponding to 
pyroglutamic acid; feature #540 (39.66 min - 1.35s), malic acid; feature #50 (26.53 min - 1.02 s), threonic acid; 
feature #48 (37.23 min - 1.02 s), mannitol; feature #649 (38.15 min - 2.20 s), gluconic acid; feature #245 (36.06 
min - 1.82 s), fructose; and feature #33 (36.26 min - 1.00 s), corresponding to one of the glucose derivatives. All 
these analytes, ranked in the first thirty most informative peak-regions (% of variable contribution along F1), 
were already mapped by the targeted fingerprinting thereby their role resulted cross-validated.  
Some additional features revealed by the untargeted approach were not previously (a priori) targeted 
analysis, but indicate possible additional information that could more completely characterize the 
phenomenon under study. Features #97 and #200 (41.03 min - 1.56 s), corresponding to the N-acetyl 
glucosamine retention region; features #292 (29.34 min - 2.14 s) and #528 (33.17 min - 2.93s), possibly glycine 
derivatives tentatively identified as malonyl glycine and methyl malonyl glycine (1570 and 1695 ITS 
respectively); feature #331 (36.5 min - 3.14 s), possibly N-acetyl glutamine (1748 ITS); and feature #219 (21.76 
min - 1.36 s), glutaric acid (1269 ITS).  
A further confirmation not only on (a) the relevance of the monitored targeted analytes in describing 
the metabolic derangement, but also on (b) the necessity of extending the list of known analytes to better 
characterize the phenomenon is evident by observing the PCA results when peak-region features from CS and 
FL sub-populations were analyzed (Figure 6B). The FL population is again more dispersed on the Cartesian 
plane compared to the control samples, but it is coherently distributed along F3 with experiment timing as in 
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the case of targeted elaboration (also in the PCA of Fig. 2C). In addition, the first Principal Component (F1) 
describes a higher portion of the total variance (51.9 % F1 Fig. 6B vs. 32.2% of Fig. 2C).  
As far as the additional analytes are concerned, N-acetyl glucosamine was 70 (FL) and 30 (FS) times 
higher in dietary-manipulated groups than in the control group. A similar trend was observed for methyl-
malonylglycine, which was 12 (FL) and 8 (FS) times higher than in the CS group; malonylglycine showed an 
average a fourfold increase, of statistical relevance, only in the FL group, while glutaric acid was 2.5 (FL) and 2 
(CS) times higher than in FS group. 
 
Targeted quantitative fingerprinting  
Quantitative analysis was run by 1D GC-MS on a priori selection of target analytes implemented with 
some informative metabolites indicated by the UT fingerprinting. The list includes compounds that were 
correlated with a more drastic dietary insult [25], early biomarkers of prediabetic/insulin resistance 
phenotypes as well as related hepatic and renal dysfunctions. 
Quantitative data affords reliable comparisons and help in evaluating possible deviations from 
physiological or reference values independently from the analytes response factors and system dynamic range. 
Highly abundant or variably distributed analytes, such as some of the monosaccharides (glucose, fructose and 
galactose), when accurately quantified, reveal informative trends along experiment timing and between sub-
populations. Analyte distributions in the samples are visualized as heat-maps (based on analytes concentration 
in mg/L of urine - data are displayed as absolute concentrations (SF2a) or normalized concentration vs. 
creatinine content (SF2b)) and provided as Supplementary material (Supplementary Figures 2a and 2b). 
Hierarchical clustering based on Euclidean distances was also performed to highlight those analytes with an 
higher informative role in describing the metabolic derangement. As illustrated in SF2a and SF2b raw and 
normalized data have comparable information potential as their clustering is the same. Some insights on single 
metabolites distribution will follow. 
Fructose, for example, was 11 times more abundant in the FL group than in the control (CS) while in the 
FS diet group it showed a 4 fold increase. GC×GC data, on the other hand, exhibited increases of 9 fold (FL vs. 
CS) and 4 fold (FS vs. CS), in agreement with quantitative data. Hippuric acid, was 3.2 (FL) and 1.3 (FS) times 
higher than in the control, confirming the trend observed by GC×GC, while citric acid showed a 1.5 fold 
increase, of statistical relevance just in the FL diet group. 
To cross-validate fingerprinting results (response data by targeted GC×2GC-MS/FID and quantitative 
data by GC-MS), a Multiple Factor Analysis (MFA) on the targeted peaks distribution was performed. MFA 
makes it possible to analyze two data matrix/tables simultaneously and provides results capable of assessing 
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the relationship between the observations (sample sub-classes) and the variables (targeted analytes). For each 
data matrix/table, PCA is performed first, then the value of the first eigenvalue of each analysis is stored and 
used to weight the two matrix/tables in a second step of the analysis. Results, expressed as RV coefficients, 
indicate to what extent the tables/variables distributions are related two-by-two. The more variables from the 
GC×2GC-MS/FID method are related to the GC-MS quantitative counterpart, the higher the RV coefficient 
(variation range 0-1). In this case, the mutual correlation between the two data sets was 0.854, indicating a 
good overall consistency between fingerprints informative content.  
More intuitively, the MFA map of the projected points, shown in Figure 7 and including control (CS) and 
liquid fructose (FL) individuals illustrates sample distributions resulting from the information provided by the 
two data-sets. Lines connect each single observation to its relative position (projection) on the two 
independent PCA charts (GC-MS method - “Table 1” and GC×2GC-MS/FID method - “Table 2”). The projected 
points correspond to supplementary observations for which only the information provided by one table is 
taken into account, the other tables being transformed to 0s. The chart based on CS and FL diet groups, where 
combining the first two PC (F1 and F2) the total explained variance raises the 43.38 %, the two sub populations 
are clearly distinguishable. . 
 
 
Urine fingerprint evolution by visual features analysis  
The last part of this study focuses on a fingerprinting approach based on visual features. Visualization 
suitable for rapid and effective pair-wise pattern comparisons, giving the possibility of monitoring variations 
during experimentation from single individuals as in the personalized medicine applications [9]. Of great 
interest in this direction is the possibility to monitor metabolic changes in a single subject to better staging the 
disease.  
Visual features fingerprinting, also defined as image comparison, is one of the earliest introduced in 
GC×GC data elaboration[10, 35] and is very effective to capture distinctive 2D patterns, compare them on an 
untargeted basis to promptly reveal compositional differences [18, 25, 36–38] The approach is fully automated, 
and when applied after UT fingerprinting, provides information about targeted or untargeted peak-regions 
variations between pair-wise compared samples. 
The example of Figure 5 refers to Mouse #40 urine samples obtained at 12 weeks (Figure 5A) of dietary 
regimen with liquid fructose supplementation (averaged normalized image of two analytical replicates) 
considered as the analyzed image versus the urine samples collected at 6 weeks (Figure 5B) (averaged 
normalized image of two analytical replicates) considered as the reference image. The resulting image (Figure 
5C) is rendered as “colorized fuzzy ratio”; the difference at each data point between aligned pair-wise images is 
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computed and colored green, when positive (larger detector response in the analyzed image (T12)) or colored 
red, when the difference is negative (larger detector response in the reference image (T6)). Brightness depends 
on the magnitude of the responses, white saturation indicates pixels/regions with detector responses nearly 
equal in pair images. 
Previously processed 2D chromatograms submitted to the image comparison already were mapped by 
the peak-regions template, with the 2D peaks identity (if known) or unique identification numbering (#) for 
unknowns included as metadata for visual tracking of differences. Informative variations (positive trends and 
negative trends) are registered for analytes listed in Figure 5C (Normalized 2D Peak Volume variations are also 
reported) and visually tracked on the colorized differential image with yellow/red contour lines.  
Fingerprint variations are perfectly coherent with the trends observed for the entire sub-population: 
fructose (here mapped in its two derivatized forms), 2-keto glutaric, citric, succinic, and malic and lactic acid all 
showing a negative trend along experiments timing from 6 to 12 weeks, confirming the evidence of a 
homestatic adaptation to the dietary insult. On the other hand, analytes markedly increased in the week 12 
samples are acyl glycine derivatives (N-crotonyl glycine, N-isovaleroyl glycine, N-phenyl acetyl glycine N-
carboxy-glycine and hexanoyl glycine), L-threonic acid, L-threonine, and glucose.  
Visual features methods provide a direct and prompt approach to localize analytes with large variations 
between pairs, confirming (or not) the individual trends within the sub-populations, but, at the same time, 
highlighting specific metabolism alterations.  
 
Conclusions 
Experimental results obtained by an advanced fingerprinting approach to study the evolution of the 
urinary metabolic signature in mice under dietary manipulation confirmed some of the expectations and 
provided useful information to understand better the systemic effect of the dietary differences. 
In particular: 
1) UT fingerprinting on 2D data obtained by GC×2GC-MS/FID cross-validates the informative role of a series of 
small metabolites excreted with urine in mice subjected to an high fructose intake (solid or liquid form) 
compared to those fed by a control diet. Metabolites whose quantitative variations were considered 
statistically relevant are: fructose, glucose, glycine and some of its acyl-derivatives (N-carboxyglycine, N-
butyrylglycine, N-isovaleroylglycine, N-phenylacetylglycine), uric acid, hippuric acid, citric acid, threonic acid, 
malic acid, succinic acid, 2-ketoglutaric acid, and tartaric acid. 
2) The UT fingerprinting based on peak-regions extended the comparative process to a higher number of 
features while confirming the targeted analysis result. In addition, additional insights on the phenomenon were 
obtained with new targets highlighted as discriminant: two glycine acyl-derivatives (malonylglycine and methyl-
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malonylglycine), N-acetylglutamine, and glutaric acid. These are highly informative compounds, with roles 
connected with fructose metabolism, so they merit future in-depth studies.   
3) Individual variations (within groups and along the timing of the experiments) suggested the adoption of 
visual features approaches to promptly monitor metabolites variations. The results of image comparison on a 
single mouse for urines collected after six and twelve weeks were in line with those derived from the global 
population, but informed on the effect of the diet on a single individual. 
4) Quantitative analysis obtained by external calibration and GC-MS confirmed the trends observed by GC×GC-
MS/FID, providing consistent and reliable information on the real impact of dietary manipulation. Quantitative 
data on metabolites excretion could be the starting point of a complete and interdisciplinary evaluation of the 
real impact of the diet in the mice physiological status.  
Perhaps most notably, our results lead to the identification of different urine metabolite fingerprints 
recorded for the two fructose groups. These findings are very important as they confirm and further extend on-
going observations on the different toxicological impacts of solid vs liquid fructose supplementation. 
Specifically, the FL urine samples consistently were differentiated and clusterized independently from the 
others, suggesting that metabolic alterations are more significant. Overall, these data suggest that the 
approach here proposed could be used for better stratifications of populations which at first glance seem to be 
exposed to the same metabolic insult (fructose overconsumption) but their metabolic profiles are affected by 
slight differences in the dietary manipulation (here solid vs. liquid form). 
Further studies are required to test whether the selected metabolites might be useful as diagnostic 
tools and to reveal the biological mechanisms that result in changes in the levels of certain metabolites in the 
pathogenesis of fructose- induced metabolic impairments. 
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Tables Caption  
Table 1: diet details, number of animals per group, timing of experiments and number of analyses. 
Table 2: list of targeted compounds from GC×2GC-MS/FID analysis; compounds are listed together with 
retention times (1tR ; 2tR), intermediate precision (relative standard deviation - RSD%) estimated on 108 
runs, experimental and tabulated linear retention indexes (ITS).  
Figure Captions 
Figure 1: 2D data elaboration workflow combining targeted and untargeted investigation 
Figure 2: Principal component analysis (PCA) scores plot referred to: (2A) all targeted analytes distribution 
across 108 runs; (2B) targeted analytes with a statistically relevant variability between classes and Fisher 
values above 5.14; (2C) sub-set of individuals fed by control diet (CS) and liquid fructose (FL); (2D) sub-
set of individuals fed by control diet (CS) and solid fructose (FL).  
Figure 3: Univariate statistics (by scatter diagrams) on 2D normalized volumes between sub-populations: (3A) 
fructose trend between populations (left side) and (right side) within the liquid fructose (FL) group along 
timing (1,6,12 weeks); (3B) Phenyl acetyl glycine trends populations (left side) and (right side) within the 
liquid fructose (FL) group along timing (1,6,12 weeks). 
Figure 4: glucose normalized responses between diet populations and experiment timings. 
Figure 5: 2D patterns (MS signal- Full scan acquisition) of urine samples collected at 12 weeks - analyzed image 
(5A) and at 6 weeks - reference image (5B) from Mouse #40 fed with liquid fructose supplementation. 
Red areas located untargeted peak-regions delineated by the UT fingerprinting work-flow. Green 
areas/peak-regions were excluded by the untargeted elaborations since they correspond to column 
bleeding and/or derivatization reagents interferences. Comparative visualization (5C) is rendered as 
“colorized fuzzy ratio” and reveals compositional differences (normalized responses) between the two 
urine samples. Targeted compounds with meaningful variations are listed on the right end of the image 
together with the relative response differences.  
Figure 6: Principal component analysis (PCA) scores plot referred to: (6A) normalized 2D volumes of all 
untargeted peak-regions connoted by a meaningful variation across the set (F value > 5.14 - i.e., 266 
over 380 peak-regions) and from all individuals; (6B) refers to control diet and liquid fructose 
populations only.  
Figure 7: Chart of the projected points obtained by Multiple Factor Analysis (MFA) on the targeted peaks 
distribution as obtained by GC-MS accurate quantitation (Table 1 in samples’ tag) and by GC×2GC-
MS/FID as semi-quantitative profiling method (Table 2 in samples’ tag). Lines connect each single 
observation to its relative position (projection) on the two independent PCA charts. The chart refers to 
CS and FL diet groups. 
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Table 1 
Diet Group Diet Energy balance calories  % n° of animals Timing  weeks 
Analytical 
replicates 
Number of 
analytial runs 
      
Control (CS)  carbohydrates 62.1%  
 [36.2% starch, 14.9% 
dextrin and 11% sugar] 
 fats 5.1%  
 fibres 5%  
 proteins 17.6% 
 
Drinking tap water 
6 1(basal) 6,12 2 36 
Liquid 
fructose (FL) 
 carbohydrates 70%  
 [8.9% starch, 1% sugar, 
60% fructose liquid 
solution] 
 fats 10%  
 proteins 20% 
 
Drinking fructose solution (60% 
w/w and citric acid as additive) 
6 1(basal) 6,12 2 36 
Solid 
fructose 
(FS) 
 carbohydrates 70%  
 [8.9% starch, 1% sugar, 
60% fructose solid 
form] 
 fats 10%  
 proteins 20% 
 
Drinking tap water  
6 1(basal) 6,12 2 36 
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Table 2 
Analyte 
1D Retention time 1tR (min) 2D Retention time 2tR (sec)   
Mean Stdev RSD Mean Stdev RSD experimental ITS reference ITS 
$Pyruvic acid 9.99 0.12 1.15% 1.04 0.01 1.02% 1059 1099 
$Lactic acid 10.36 0.11 1.04% 0.97 0.02 1.59% 1067 1066 
$L-Alanine 11.72 0.13 1.09% 0.98 0.03 2.79% 1110 1095 
N-carboxy-glycine 13.01 0.10 0.79% 1.27 0.03 2.40% 1147 - 
$L-Isoleucine 13.48 0.28 2.06% 1.26 0.04 3.50% 1158 1286 
$3-Hydroxybutyric acid  13.61 0.11 0.79% 1.01 0.02 2.41% 1168 1148 
$2-Keto-3-methyl-N-valeric acid 14.36 0.10 0.71% 1.14 0.02 1.60% 1189 1206 
$Malonic acid 15.19 0.10 0.68% 1.32 0.02 1.44% 1218 1216 
$L-Valine 15.63 0.06 0.38% 1.00 0.00 0.00% 1227 1224 
$L-Leucine 17.56 0.10 0.57% 1.00 0.01 1.21% 1273 1272 
$Glycerol 17.79 0.09 0.48% 0.87 0.03 3.27% 1292 1289 
Phosphate  18.09 0.15 0.83% 1.41 0.04 2.59% 1299 1290 
$Glycine 18.65 0.11 0.57% 1.03 0.01 1.16% 1318 1110 
$Succinic acid 18.86 0.09 0.47% 1.34 0.03 2.27% 1322 1321 
$Fumaric acid 19.85 0.09 0.47% 1.30 0.02 1.56% 1355 1353 
2,3-Dihydroxybutanoic acid 20.42 0.10 0.47% 1.04 0.03 2.61% 1366 1439 
$L-Threonine 21.43 0.07 0.30% 1.04 0.00 0.00% 1395 1377 
$L-Aspartic acid  22.34 0.00 0.00% 1.54 0.00 0.00% 1418 1422 
N-Butyryl glycine 22.92 0.08 0.36% 2.37 0.05 2.07% 1431 1505 
N-Isovaleroylglycine 24.23 0.09 0.37% 2.26 0.03 1.45% 1467 1502 
$Malic acid 24.63 0.07 0.29% 1.22 0.03 2.06% 1480 1478 
N-Crotonylglycine 24.88 0.08 0.33% 2.51 0.04 1.74% 1493 1482** 
Pyroglutamic acid  25.38 0.08 0.31% 1.90 0.04 1.96% 1526 1523 
L-Threonic acid 27.08 0.08 0.28% 1.03 0.03 3.39% 1579 1545 
$2-keto glutaric acid 27.20 0.08 0.28% 1.45 0.06 3.89% 1581 1572 
Hexanoylglycine 28.59 0.08 0.27% 2.30 0.05 2.34% 1632 1648** 
$Tartaric acid 29.34 0.08 0.26% 1.17 0.03 2.95% 1668 1665 
3-Ureidopropionic acid  29.53 0.11 0.36% 2.95 0.06 2.13% 1663 1676 
Xilose  30.50 0.07 0.24% 0.91 0.03 3.56% 1684 1645 
$Xilitol 31.31 0.07 0.23% 0.89 0.01 1.57% 1695 1694 
$Ribitol 31.75 0.07 0.21% 0.98 0.04 3.66% 1717 1712 
cis-Aconitic acid 31.97 0.07 0.23% 1.44 0.04 2.45% 1751 1749 
α-Glycerophosphate 32.66 0.07 0.20% 1.41 0.03 2.33% 1763 1751 
Cl-Phenylalanine (ISTD 1) 33.03 0.08 0.23% 1.49 0.02 1.46% 1789 - 
$Hippuric acid 33.93 0.08 0.23% 2.52 0.04 1.40% 1823 1820 
$Citric acid 34.12 0.08 0.23% 1.31 0.03 2.61% 1840 1838 
N-Phenyl acetyl glycine 35.03 0.08 0.23% 2.58 0.05 2.03% 1855 1848 
$Fructose (1) 35.67 0.08 0.22% 0.95 0.03 3.40% 1867 1867 
$Fructose (2) 35.95 0.08 0.23% 0.94 0.03 3.12% 1876 1875 
$Glucose (1) 36.35 0.14 0.37% 0.99 0.02 2.18% 1891 1902 
$Galactose (1) 36.70 0.10 0.26% 0.99 0.05 5.34% 1902 1883 
$L-Tyrosine (2TMS) 36.71 0.06 0.16% 1.39 0.00 0.00% 1905 1934 
$Galactose (2) 36.77 0.43 1.18% 0.93 0.04 4.81% 1918 1926 
$Mannitol 37.22 0.08 0.23% 0.95 0.03 3.37% 1927 1925 
p,p'-Dibromobiphenyl (ISTD 2) 37.80 0.08 0.21% 1.98 0.03 1.72% 1959 - 
D-Gluconic acid  39.12 0.06 0.15% 1.03 0.01 1.30% 2037 1997 
N-Acetyl-D-glucosamine 40.57 0.10 0.24% 1.50 0.04 2.55% 2121 2072 
$Myo-inositol 40.69 0.06 0.14% 1.05 0.03 2.58% 2128 2126 
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$Uric acid 40.91 0.06 0.15% 1.36 0.04 3.06% 2130 2130 
$L-Tryptophan 42.24 0.07 0.16% 1.59 0.03 1.89% 2181 2193 
Stearic acid 43.27 0.06 0.14% 1.23 0.02 1.62% 2240 2236 
Pseudouridine 46.07 0.06 0.14% 1.32 0.04 2.73% 2378 2375 
Sucrose 52.23 0.09 0.16% 1.13 0.03 2.85% 2655 2653 
        $ analytes confirmed by reference compounds and external calibration 
** reference ITS on standard apolar column (DB-1 and equivalents)   
 
